Janet Woodcock, FDA, on Biomarker Development and the Future of Clinical Trials

0:00 | Nov 13th, 2014

Guest: Janet, Woodcock, MD, Director, CDER, FDA Bio and Contact Info Listen (4:41) No agency charged with better translational outcomes